Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.5 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |